Climate Change Data

Environmental Metrics

ESG Focus Areas

• Economic Performance
• Environmental Footprints
• Social Responsibility

Environmental Achievements

• Commissioned a zero liquid discharge plant (ZLDP) at Miryalguda plant, recycling 100% of industrial effluents.
• Reduced water usage per unit sale.
• Reduced hazardous and non-hazardous waste by 8%.
• Reduced CO2 emissions by over 500 tons in the Generics plant, resulting in annual savings of Rs. Six million.
• Achieved ISO 14001 and OHSAS 18001 certifications for Generics plant.

Social Achievements

• Implemented the CAP-SCOPE project, benefiting over 7000 children.
• Launched LABS program, providing livelihoods to more than 15,000 unemployed youth.
• Supported Naandi Foundation's initiatives, impacting over a million underserved people.
• Implemented the 'Power of 10' initiative, where employees contribute to Naandi Foundation.
• Created Ankur, a corporate university, for employee development.

Governance Achievements

• Established a robust SHE policy and management system.
• Implemented a global matrix organizational structure.
• Awarded the ICSI National Award for Excellence in Corporate Governance in 2002.

Climate Goals & Targets

Environmental Challenges

• Water security threats.
• Greenhouse gas emissions.
• Wastewater discharge.
• Hazardous waste management.
• Safety incidents at construction sites.
• Transportation of hazardous materials.

Mitigation Strategies

• Installed 250 water meters, conducted process reviews, and created awareness campaigns to reduce water usage.
• Implemented energy conservation initiatives, resulting in significant CO2 emission reductions.
• Invested in multiple effect evaporators for wastewater treatment and recycling.
• Implemented responsible waste disposal practices, including incineration, landfilling, and recycling.
• Developed internal guidelines for contractor safety and training manuals for contract workers.
• Developed detailed guidelines for the transportation of hazardous materials by road.

Supply Chain Management

Supplier Audits: First-line suppliers inspected for statutory compliance.

Responsible Procurement

• Continuous advice and periodic meetings with suppliers regarding SHE.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: Global Reporting Initiative (GRI)

Certifications: ISO 14001, OHSAS 18001

Third-party Assurance: Ernst & Young Pvt. Ltd.

Awards & Recognition

• Express Pharma Pulse Award for excellence in research
• National Award from CII for energy conservation
• ICSI National Award for Excellence in Corporate Governance (2002)
• Various awards for employee engagement and HR practices.

Environmental Metrics

ESG Focus Areas

• Economic performance
• Environmental footprint
• Social responsibility

Environmental Achievements

• Reduced water consumption by 4%
• Reduced effluent discharge by 68%
• Commissioned zero liquid discharge plants at three API units
• Achieved a 12673 KL/annum reduction in effluent generation at API Unit 2
• API Unit 2 won CII awards for energy and water efficiency

Social Achievements

• Increased R&D investment by 41%
• Implemented DuPont's STOP program, reducing first-aid cases significantly
• Created 20,000 livelihoods through LABS program (against a target of 10,000)
• Invested 8016 person-days in employee training
• Improved offer-to-acceptance ratio in recruitment to 96%

Governance Achievements

• Strengthened internal controls through SOX compliance
• Implemented a Code of Business Conduct and Ethics
• Established a three-tier SHE management structure

Climate Goals & Targets

Environmental Challenges

• 3% decline in revenues
• Decline in revenue from key products
• Increased greenhouse gas emissions due to increased energy consumption
• Decline in hazardous material transport compliance

Mitigation Strategies

• Increased investment in drug discovery and pipeline building
• Implemented energy-saving measures and process improvements
• Implemented measures to improve hazardous material transport compliance
• Implemented cost control measures and process excellence initiatives

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Global Reporting Initiative

Certifications: ISO 14001, OHSAS 18001

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Best Management Award from Andhra Pradesh State Government
• CII Energy & Water Management Awards
• WorldStar award for packaging excellence

Environmental Metrics

ESG Focus Areas

• Affordable and Innovative Medicines
• Product Responsibility
• Being an Employer of Choice
• Environmental Management and Climate Change
• Sustainable Sourcing
• Caring for Communities

Environmental Achievements

• Reduced wastewater discharged to 3,740 m³ compared to 37,000 m³ the previous year.
• Reduced hazardous waste disposed by 37% to 13,045 tons.
• 28% of water requirement met through recycled water (increased by 9% to 558,000 m³).

Social Achievements

• Sparsh program benefited 4,250 underprivileged cancer patients.
• Power of 10™ employee giving program raised over INR 2,440,000.
• Various community initiatives in education and livelihood development.

Governance Achievements

• Implementation of Quality by Design (QbD) approach.
• Enhanced regulatory compliance and proactive engagement with regulatory bodies.
• Increased automation to enhance quality, reliability, and consistency.

Climate Goals & Targets

Environmental Challenges

• Global economic slowdown and pricing pressures.
• Increased government regulations.
• Two product recalls.
• Environmental concerns about water usage and discharge.
• Impact of global epidemics on the industry.

Mitigation Strategies

• Strategic alliances with GSK and other companies.
• Implementation of Quality by Design (QbD) and enhanced quality systems.
• Proactive engagement with regulatory bodies.
• Water conservation initiatives and wastewater treatment facilities.
• Self-initiated voluntary product recalls and improved pharmacovigilance.

Supply Chain Management

Responsible Procurement

• Sustainable sourcing initiatives; working with suppliers to improve their sustainability quotient.

Climate-Related Risks & Opportunities

Environmental Metrics

ESG Focus Areas

• Environment
• Employee Well-being
• Stakeholder Engagement
• Human Rights
• Equitable Development
• Customer Value

Environmental Achievements

• All plants are zero discharge; 86% of organic waste upcycled; more than 10% of energy needs met from renewable sources; 31 energy conservation projects implemented, saving ₹63.54 million; solar energy consumption of 39.0 million kWh, reducing carbon footprint by 38,611 MT of CO2e.
• Reduction in resource use (energy, water, raw materials) for Fexofenadine, Sumatriptan, and Azacitidine.

Social Achievements

• Extended Self-Managed Teams (SMTs) program; People Management Effectiveness Programme; rolled out the People Management Effectiveness Programme; Community Health Intervention Programme (CHIP) benefited over 7,500 people; School Improvement Programme benefited more than 12,000 students; trained over 7,000 young adults for livelihood; Annual Week of Giving.
• Launched Medznat, a digital information platform in Russia for healthcare professionals.

Governance Achievements

• Rewired quality systems; upgraded quality incident investigation (QII) system; implemented Intelligent Integration project for supply chain; institutionalised PACE, a productivity enhancement programme; piloted a business continuity plan; strengthened Quality Management Systems; implemented Enterprise Risk Management (ERM) initiative; buyback of shares.

Climate Goals & Targets

Environmental Challenges

• USFDA warning letter following inspections of three plants, leading to delayed product launches and increased costs; economic problems in Russia and devaluation of the rouble; economic crisis in Venezuela, restricting repatriation of funds beyond US$4 million.

Mitigation Strategies

• Comprehensive plan of corrective and remedial actions submitted to USFDA; strengthening pipeline with complex generics, better OTC offerings, and increasing institutional/hospitals business; decided to supply medicines to Venezuela only against letters of credit or pre-payment.

Supply Chain Management

Responsible Procurement

• Code of Conduct for partners; 60% of procurements from domestic producers; initiatives to improve capacity and capabilities of local producers.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Global Compact

Sustainable Products & Innovation

• Fexofenadine, Sumatriptan, Azacitidine; Zembrace™ SymTouch™; Sernivo™ Spray.

Environmental Metrics

ESG Focus Areas

• Affordable and innovative medicines
• Being an employer of choice
• Caring for communities
• Environmental management and climate change
• Sustainable sourcing
• Product responsibility

Environmental Achievements

• Achieved zero hazardous waste to landfill across all API manufacturing units in India.
• Reduced specific energy consumption by 6.7% over the previous year.
• Reduced specific water consumption by 58% compared to the base year 2010 (40% target by 2020 achieved).

Social Achievements

• Launched Purple Health®, a patient-centric innovation platform.
• Implemented various initiatives under Purple Health® (PHAP, SPARSH, MITR, CHEER, Livpositive, Ecocamp, Purple Pack®) improving patient adherence and access to medicines.
• Increased the number of women in the workplace significantly, ranking first in the “Diversity in Asia” report by Carnstone.

Governance Achievements

• Revised Code of Business Conduct and Ethics (COBE) to reflect changing stakeholder expectations.
• Implemented a control tower approach for ensuring overall compliance with product quality requirements.
• No Class 1 product recalls during the reporting year.

Climate Goals & Targets

Environmental Challenges

• Changing market dynamics and increased competition.
• Shift in regulatory enforcement mechanisms.
• Pricing pressures in emerging markets.
• Economic slowdowns in some markets.
• Lower offtake of some key molecules in the API portfolio.
• Loss of a contract worker highlighting the criticality of workplace safety.

Mitigation Strategies

• Integrated all manufacturing processes and support functions under a unified 'Global Quality Management System'.
• Significant investments in upgrading manufacturing infrastructure and quality systems.
• Structured capability building across all levels.
• Integrating safety and quality into the core of the manufacturing system.
• Implementing reliability centered maintenance (RCM) approach for maintenance operations.
• Mechanization and automation initiatives to improve efficiency and reduce errors.

Supply Chain Management

Supplier Audits: Independent third-party audits; 100% of high-risk suppliers have corrective action plans.

Responsible Procurement

• Supplier Code of Conduct based on ILO, UDHR, SAI, ETI, and GRI standards; procedures to procure from local and small producers; supply chain excellence initiatives.

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards: Core option

Certifications: ISO 14001, OHSAS, SA8000

Third-party Assurance: DNV GL Business Assurance India Private Limited

UN Sustainable Development Goals

• Goal 3: Good health and well-being
• Goal 6: Clean water and sanitation
• Goal 7: Affordable and clean energy
• Goal 9: Industry, innovation and infrastructure
• Goal 12: Responsible consumption and production
• Goal 13: Climate action

Sustainability activities linked to relevant UN SDGs.

Sustainable Products & Innovation

• Differentiated formulations for easier and calibrated dosages; green chemistry initiatives in drug development and manufacturing (Sildenafil, Rivaroxaban).

Awards & Recognition

• Golden Peacock Award for Sustainability 2016
• Listed in Dow Jones Sustainability Indices for emerging markets
• Frost & Sullivan Green Manufacturing Excellence Award (GMEA)
• CII Environmental best practices award

Environmental Metrics

ESG Focus Areas

• Environmental Management and Climate Change
• Sustainable Sourcing
• Caring for Communities
• Being an Employer of Choice
• Providing Affordable and Innovative Medicines
• Product Responsibility

Environmental Achievements

• 188 energy efficiency/conservation projects implemented, resulting in ₹233.7 million cost savings and avoided carbon emissions of 96,364 tCO2e
• 8.92% reduction in indirect energy consumption
• 7.7% renewable energy in total energy mix; 49.4 million kWh solar energy consumption (avoided 46,473 tCO2e)
• 42,165 tCO2e carbon emission avoided from Air Vs Sea shipment initiative
• 21% reduction in specific energy consumption from 2009-10 baseline
• 59% reduction in specific water consumption from 2009-10 baseline
• 20,298 MT waste co-processed and recycled
• 51% reduction in hazardous waste generation from 2009-10 baseline
• Achieved zero waste to landfill at all API facilities

Social Achievements

• LIV Positive program benefited 1743 patients
• SPARSH program benefited 2000 patients
• Jagruti program had 148 new patient enrollments
• 8 flagship medical education programs with high Net Promoter Scores (NPS)
• ₹262 million total contribution towards community development (2.05% of profit after tax)
• 327,104 people benefited from community-based initiatives
• Inclusion in the Bloomberg Gender-Equality Index for the second time

Governance Achievements

• Strong and independent Board maintaining high corporate governance standards
• Full compliance with SEBI and NYSE corporate governance norms
• Robust governance structure and periodic internal audits supporting Code of Business Conduct and Ethics (COBE) implementation
• Comprehensive Enterprise Risk Management (ERM) system

Climate Goals & Targets

Environmental Challenges

• Regrettable attrition of entry-level hires in the second year (<=10%)
• Supply chain disruptions due to changes in China's environmental policies
• Limited availability of high-caliber talent in the pharma industry
• Rapid technological change

Mitigation Strategies

• Proficient performance appraisal systems and on-the-job training programs
• De-risking single sources out of China and focusing on India's domestic market
• Upskilling initiatives and comprehensive training needs analysis
• Investing in the brightest minds and continuously refreshing talent pool

Supply Chain Management

Supplier Audits: All critical Tier 1 suppliers audited every 2-4 years; risk-based audit system

Responsible Procurement

• Supply chain code of conduct
• Vendor risk assessment framework
• Emphasis on local procurement
• Integration of sustainability criteria in supply chain management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI Standards – Core option, International Integrated Reporting framework

Certifications: ISO 14001, OHSAS 18001, SA 8000 (some facilities)

Third-party Assurance: DNV GL Business Assurance India Private Limited

Sustainable Products & Innovation

• Purple Pack intelligent packaging
• Biodegradable paper fiber board drums
• Electronic medication guides

Awards & Recognition

• FTSE4 Good Index Series
• DJSI Emerging Markets Index
• India Pharma CSR Program of the Year
• Top 50 Pharma Innovation Award
• Excellence in Pharma: IT, eHealth & Digitization
• Sustainable Organization of the Year 2019 – Pharma Sector
• CII Environment Excellence Award
• CII Environmental Best Practice Award
• SHE Excellence – Pharmaceutical Company of the Year
• Gold 4 Star – OHSSAI Award 2019 for Sustainability
• Operational Excellence in Supply Chain award (3 times)

Environmental Metrics

ESG Focus Areas

• Environment
• Social
• Governance

Environmental Achievements

• Reduced specific water consumption by 61% (target 40%)
• Reduced specific hazardous waste generation by 48% (target 40%)
• 100% of non-hazardous waste (17,984 tons) recycled/sold
• Reduced specific energy consumption by 31% (target 40%)
• Achieved 8.8% renewable energy share (target 25%)
• 48% of total freshwater consumption recycled/reused

Social Achievements

• 3% reduction in employee turnover rate compared to FY2019
• Zero fatalities
• Increased number of differently abled employees by 10%
• Total spending on CSR as a percentage of profit after tax

Governance Achievements

• No incidents of bribery or corruption
• Initiated a regulatory and physical climate risk assessment as part of TCFD

Climate Goals & Targets

Environmental Challenges

• Not disclosed

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• 67.9% of procurement budget spent locally

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: SA 8000:2014 (most facilities)

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Many awards listed in the report (see page 6)

Environmental Metrics

ESG Focus Areas

• Improving communities' health
• Building resilient health systems
• Investing in digital healthcare solutions
• Resource efficient buildings and production processes
• Energy and emissions management
• Water management
• Waste management

Environmental Achievements

• Reduced carbon emissions intensity by 27% (against the base year FY2018)
• Achieved 74% water neutrality potential
• Achieved 100% plastic waste neutrality in India (two years ahead of 2023 goal)
• 98.73% of hazardous waste sent as fuel to cement industries and recyclers
• Over 70% of global manufacturing sites are Zero Liquid Discharge facilities

Social Achievements

• Donated INR 360.8 million for community development and INR 50 million to the Andhra Pradesh Chief Minister's Relief Fund
• Mobilized essential resources including INR 50 million worth of N95 masks
• Served 2.5 million meals to communities
• Continued flagship Community Health Intervention programme (CHIP) supporting 192,545 people in 155 villages
• Provided bereavement support to families of colleagues who lost their lives due to COVID-19

Governance Achievements

• Became a full member of the Pharmaceutical Supply Chain Initiative (PSCI)
• Improved company-wide gender diversity to 17.18%
• 167 concerns received through Ombudsperson reporting channels, all investigated and acted upon

Climate Goals & Targets

Environmental Challenges

• Supply chain disruptions due to the COVID-19 pandemic
• Climate change causing a rise in sea level and increasing the risk of flooding
• Technology disruptions impacting business processes
• Water crisis

Mitigation Strategies

• Activated Business Continuity Plan (BCP)
• Implemented energy conservation projects reducing emissions and saving costs
• Increased use of renewable power (21% of total power consumed)
• Developed alternative water sources
• Implemented Zero Liquid Discharge (ZLD) water treatment at 15 of 21 global manufacturing facilities
• Developed location-specific responsive mitigation plans for climate-related physical risks
• Investing in the protection of data and information technology to reduce technology-related risks

Supply Chain Management

Supplier Audits: 99 suppliers audited under ESG parameters

Responsible Procurement

• Supplier Code of Conduct (SCOC) modeled on PSCI Principles

Climate-Related Risks & Opportunities

Physical Risks

• Flooding
• Earthquakes
• Droughts

Transition Risks

• Phase-out of high-carbon fuels

Opportunities

• Renewable energy projects
• Green chemistry
• Energy efficiency improvements

Reporting Standards

Frameworks Used: GRI Standards: Core option, UN Global Compact, UN Sustainable Development Goals (SDGs), Science-Based Targets initiative (SBTi), Task Force on Climate-related Financial Disclosures (TCFD)

Certifications: ISO 14001 (8 global formulations manufacturing sites)

Third-party Assurance: DNV

UN Sustainable Development Goals

• Goal 3 (Good Health and Well-being)
• Goal 7 (Affordable and Clean Energy)
• Goal 8 (Decent Work and Economic Growth)
• Goal 12 (Responsible Consumption and Production)
• Goal 13 (Climate Action)

Initiatives mapped to SDGs throughout the report

Sustainable Products & Innovation

• CLOHEX -NS interdental brush with recycled packaging

Awards & Recognition

• CPhI Pharma Awards 2020 (Excellence in Pharma: Sustainability)
• CMO Leadership Awards 2020
• North American CandE Awards 2020
• UN Women 2020 WEP Awards
• CII-ITC Sustainability Awards 2020
• CII SCALE Award 2020
• 28th Infiexion Pharma Supply Chain & Cold Chain e-Expo & Awards
• SEEM National Energy Management Awards 2020
• Global Generics & Biosimilars Awards 2020

Environmental Metrics

ESG Focus Areas

• Environmental stewardship
• Access and affordability of medicines
• Equity, diversity and inclusion
• Good governance

Environmental Achievements

• Reduced emissions of 21,978 tCO2e
• Reduced water intensity by 13% compared to FY21
• 99% waste neutral globally
• No discharge of wastewater to the environment
• 100% plastic neutral in India
• 26% power sourced from renewable sources
• Reduced downstream transportation emissions by 15,215 MT CO2e by shifting from air freight to sea freight

Social Achievements

• Reached ~674 million patients globally
• 83% actively engaged employees
• 98.1% Employees returned to work after parental leave
• 62.9 hours Training and development per FTE
• ~0.5 million Total healthcare stakeholders trained
• 100 million People from 9000 Indian rural towns reached through rural access programme, Vistara
• ~28 million Patients reached in low- and middle-income countries
• 100% Workforce paid more than minimum wages and covered by medical insurance, maternity and paternity benefits
• Over 4,25,000 individuals have been positively impacted through CSR efforts
• Trained 378 youth through core employability skills training programme for persons with disabilities

Governance Achievements

• Sustainability & CSR Board level committee formed
• 80% Independent Directors on Board
• 40% Board members are diverse based on gender or ethnicity
• Project Ethos benchmarking of business ethics policies

Climate Goals & Targets

Environmental Challenges

• Price pressures, changing market conditions and cost escalations due to supply chain disruptions
• Climate-related risks (extreme weather, regulatory changes)
• ESG risks (inadequate performance, negative ratings)
• Supply chain disruptions
• Antimicrobial resistance

Mitigation Strategies

• Investing in climate-resilient infrastructure, insurance coverage, and supply chain improvements
• Strengthening ESG policies, controls, and processes
• Developing alternative sourcing strategies
• Implementing Project Ethos to improve compliance
• Promoting responsible manufacturing practices and access to affordable medicines

Supply Chain Management

Supplier Audits: 275 suppliers underwent onsite ESG risk assessment in last three years; 40% ESG factors in supplier audits; 100% suppliers covered under the Supplier Code of Conduct

Responsible Procurement

• Supplier Code of Conduct (SCOC) modeled on PSCI Principles
• Supplier screening and assessment
• ESG framework aligned to PSCI guidelines
• Training on sustainable procurement

Climate-Related Risks & Opportunities

Physical Risks

• Extreme weather, flooding, cyclones, typhoons, hurricanes

Transition Risks

• Regulatory changes, carbon pricing mechanisms

Opportunities

• Development of energy-efficient products
• Increased demand for products and services due to climate-related health hazards
• Resource efficiency

Reporting Standards

Frameworks Used: GRI Standards: Core option, UN Global Compact Communication on Progress

Certifications: ISO 45001 (7 global formulations manufacturing units), ISO 14001 (8 global formulations manufacturing sites)

Third-party Assurance: DNV

UN Sustainable Development Goals

• Goal 3 (Good Health and Well-being)
• Goal 7 (Affordable and Clean Energy)
• Goal 8 (Decent Work and Economic Growth)
• Goal 10 (Reduced Inequalities)
• Goal 12 (Responsible Consumption and Production)
• Goal 13 (Climate Action)

Initiatives aligned with UN SDGs through various programmes and goals

Sustainable Products & Innovation

• Green chemistry initiatives
• Sustainable packaging

Awards & Recognition

• Dow Jones Sustainability Index
• S&P Global Sustainability Yearbook
• Bloomberg Gender-Equality Index
• CDP Supplier Engagement Leaderboard
• CII SCALE Award
• Frost & Sullivan-TERI Sustainability 4.0 Awards
• American Heart Association Workplace Health Achievement Index

Environmental Metrics

ESG Focus Areas

• Environmental
• Social
• Governance

Environmental Achievements

• 14% absolute reduction in Scope 1 & 2 emissions from previous financial year
• 6% absolute reduction in Scope 3 emissions from previous financial year
• 7% reduction in fresh water intensity from previous financial year
• 48% of total energy consumption is from renewable sources
• Water positive by 2025

Social Achievements

• 100% of our permanent employees and workers are covered under health and accident insurance, and maternity and paternity benefits
• 99.1% return to work rate and 83.6% retention rate for our permanent employees post parental leave
• 92% employees and 99.2% workers were provided skill upgradation training
• Positively impacted 496,618 individuals through CSR initiatives

Governance Achievements

• Sustainability and CSR Committee act as nodal Committee for ESG related matters
• No disciplinary action against Directors/KMPs/Employees/ Workers by any law enforcement agencies for charges of bribery/corruption
• 36.4% of Board members are women directors

Climate Goals & Targets

Environmental Challenges

• Regulatory compliance
• Pharmacovigilance (PV)
• Water Management
• Waste Management
• Energy and emissions management
• Talent attraction and retention
• Combating counterfeit medicines
• Business continuity
• Business ethics/bribery and corruption
• Geo-political risk
• Data security, data privacy, and cybersecurity
• Supply chain
• Product development

Mitigation Strategies

• Robust quality processes and systems
• Mature system to monitor benefit-risk profile of products
• Water management strategy involving water efficiency, alternate sources, and creating freshwater potential
• Waste management systems at all facilities
• Decarbonisation strategy focusing on energy mix, conservation, and carbon sequestration
• Analytics to measure employee performance and address skill gaps
• Comprehensive measures including DSCSA implementation and serialisation
• ERM and assurance functions to identify key risks
• Code of Business Conduct and Ethics (COBE) and Anti-Bribery and Anti-Corruption policies
• Monitoring geopolitical developments and mitigating exposure
• ISMS based on ISO 27001 and NIST Cybersecurity Framework
• Active management of third-party relationships and broad supplier base
• Upskilling employees and adopting new technologies

Supply Chain Management

Supplier Audits: 25.5% of value chain partners (India direct spend) evaluated on multiple ESG parameters

Responsible Procurement

• Supplier Code of Conduct with sustainability requirements
• ESG framework for assessing strategic suppliers

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: GRI Standards 2021, UN SDGs, NGRBC

Certifications: ISO 14001, ISO 45001, SA8000

Third-party Assurance: DNV Business Assurance India Private Limited

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• National Award for the Empowerment of Persons with Disabilities